Cutaneous Squamous Cell Carcinoma in situ
Showing 1 - 25 of >10,000
Squamous Cell Carcinoma in Situ Trial in United States (STP705, Placebo Saline)
Active, not recruiting
- Squamous Cell Carcinoma in Situ
- STP705
- Placebo Saline
-
Scottsdale, Arizona
- +5 more
Dec 13, 2022
Bowen's Disease, Cutaneous Squamous Cell Carcinoma in Situ Trial in Aventura (STP705)
Completed
- Bowen's Disease
- Cutaneous Squamous Cell Carcinoma in Situ
-
Aventura, FloridaCenter for Clinical and Cosmetic Research
Jun 8, 2022
Facial isSCC Trial in Aventura (STP705)
Recruiting
- Facial isSCC
-
Aventura, FloridaCenter for Clinical and Cosmetic Research
Aug 5, 2022
Head and Neck Squamous Cell Carcinoma, Breast Cancer, Sarcoma Trial in United States (Durvalumab, Tremelimumab, Poly ICLC)
Completed
- Head and Neck Squamous Cell Carcinoma
- +10 more
- Durvalumab
- +2 more
-
Atlanta, Georgia
- +6 more
Mar 1, 2022
Cutaneous Squamous Cell Carcinoma Trial (INCB099280)
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- (no location specified)
May 24, 2023
Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +3 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 17, 2023
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- +10 more
- Regular care with additional administration of a semi-structured interview
-
Maastricht, NetherlandsMaastricht University Medical Center+
Sep 13, 2023
Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- +2 more
-
Marlborough, MassachusettsPhio Pharmaceuticals Corp.
Aug 25, 2023
Cutaneous Squamous Cell Carcinoma in Situ (CSCCis) Trial in Australia, Belgium, United States (Cutaneous Cream application,
Terminated
- Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)
- Cutaneous Cream application
- Placebo Cutaneous Cream application
-
Phoenix, Arizona
- +7 more
Dec 9, 2020
Cutaneous Squamous Cell Carcinoma Staging Study
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- This is not an interventional study
- (no location specified)
Jan 20, 2023
Cutaneous Squamous Cell Carcinoma Trial in Tampa (Pramlintide)
Suspended
- Cutaneous Squamous Cell Carcinoma
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Disease-free Survival of High-risk Head-neck Cutaneous Squamous
Active, not recruiting
- Carcinoma, Squamous Cell
- +5 more
- Treatment
-
Maastricht, Netherlands
- +1 more
Apr 26, 2023
Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)
Not yet recruiting
- Cutaneous Melanoma
- +2 more
- Exercise Test
-
Orlando, FloridaAdventHealth Translational Research Institute
Aug 18, 2023
Squamous Cell Carcinoma Trial (MK-3475A)
Not yet recruiting
- Squamous Cell Carcinoma
- MK-3475A
- (no location specified)
Sep 11, 2023
Interobserver Variability Desmoplasia
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- +3 more
- Assessment by dermatopathologists
-
Maastricht, NetherlandsMaastricht University Medical Center+
Aug 29, 2023
Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Lausanne (FLASH RT, Conventional RT)
Not yet recruiting
- Basal Cell Carcinoma
- Cutaneous Squamous Cell Carcinoma
- FLASH RT
- Conventional RT
-
Lausanne, Vaud, SwitzerlandCentre Hospitalier Universitaire Vaudois (CHUV)
Feb 13, 2023
Squamous Cell Carcinoma, Nonmelanoma Skin Cancer, Cutaneous Squamous Cell Carcinoma Trial in Indianapolis (sentinel lymph node
Recruiting
- Squamous Cell Carcinoma
- +2 more
- sentinel lymph node biopsy (SLNB)
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Nov 15, 2022
Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)
Recruiting
- Cutaneous Squamous Cell Carcinoma
-
Amsterdam, Noord Holland, NetherlandsNKI-AVL
Oct 24, 2022
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023
Squamous Cell Carcinoma Trial in Tampa (Afatinib 40 MG)
Recruiting
- Squamous Cell Carcinoma
- Afatinib 40 MG
-
Tampa, FloridaMoffitt Cancer Center
Dec 30, 2022
Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)
Recruiting
- Cutaneous Squamous Cell Carcinoma
- Advanced Cancer
- Cemiplimab
- +3 more
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 19, 2023
Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Carrilizumab with albumin-binding paclitaxel)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- Carrilizumab with albumin-binding paclitaxel
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
May 23, 2023
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Resectable Cutaneous Squamous Cell Carcinoma of the Head and
Recruiting
- Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
- +4 more
- Cemiplimab
-
Houston, TexasM D Anderson Cancer Center
Jan 17, 2023
Advanced Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (IBI318)
Active, not recruiting
- Advanced Cutaneous Squamous Cell Carcinoma
-
Guangzhou, ChinaSun Yat-sen University Cancer Center
Oct 10, 2022